Related Experiment Video
Updated: May 4, 2026

Simple Continuous Glucose Monitoring in Freely Moving Mice
Published on: February 24, 2023
Parental sleep quality and continuous glucose monitoring system use in children with type 1 diabetes
Z Landau1, M Rachmiel, O Pinhas-Hamiel
1Pediatric Endocrine and Diabetes Service, E. Wolfson Medical Center, Holon, 58100, Israel, landau.zohar@gmail.com.
Insights
Continuous glucose monitoring systems (CGMS) did not change parents' perceived sleep quality but did increase nighttime awakenings. Parents of children with type 1 diabetes should be aware that CGMS may disrupt sleep continuity.
Area of Science:
- Pediatric Endocrinology
- Sleep Medicine
- Diabetes Management
Background:
- Type 1 diabetes management in children requires significant parental oversight.
- Continuous glucose monitoring systems (CGMS) are increasingly used to aid diabetes management.
- The impact of CGMS on parental sleep quality and patterns is not well-understood.
Purpose of the Study:
- To compare sleep quality and sleep-wake patterns in parents of children with type 1 diabetes before and during routine CGMS use.
- To assess parental self-perception versus objective measures of sleep.
Main Methods:
- Thirteen parents of children with type 1 diabetes completed the Pittsburgh Sleep Quality Index (PSQI) and a 7-day sleep diary.
- Parents wore an actigraph for one week before CGMS initiation and 4-8 weeks after routine CGMS use.
- Data were analyzed to compare sleep parameters between the two periods.
Main Results:
- Parental self-reported sleep quality (PSQI scores) remained similar before and during CGMS use (p=0.45).
- However, sleep diaries and actigraphy revealed a significant increase in nighttime awakenings and wake time during CGMS use (p=0.03 for both).
- Six parents reported severe sleep problems regardless of CGMS use.
Conclusions:
- While parents' subjective perception of sleep quality did not change with CGMS implementation, objective measures indicate a negative impact on sleep continuity.
- CGMS use appears to disrupt parental sleep patterns, increasing awakenings and wake time.
- Healthcare providers should manage parental expectations regarding sleep improvements when initiating CGMS for pediatric type 1 diabetes management.
Abstract:
To compare sleep quality and sleep-wake patterns in parents of children with type 1 diabetes before routine use of the continuous glucose monitoring system (CGMS) and while using it. Thirteen parents completed the Pittsburg Sleep Quality Index (PSQI), a 7-day sleep diary, and wore an actigraph (a wristwatch-size motion detector) during the night for 1 week before pediatric use of CGMS and 4-8 weeks after initiating routine use of the CGMS. Mean age of parents (ten mothers, three fathers) was 39 (range 32-47) years; mean age of children was 9.3 years (range 5.5-16.5 years); mean disease duration was 3.4 (range 0.6-11.2) years. PSQI total score demonstrated similar quality of sleep with and without use of the CGMS (4.6 and 4.9, respectively, p = 0.45). Six of the 13 parents reported severe sleep problems (PSQI ≥ 5) with and without the CGMS. The sleep diary indicated a greater number of awakening episodes during CGMS use than without the CGMS (1.6 and 1, respectively, p = 0.03), and actigraphy documented an increase in the number of wake bouts (22.9 and 19.7, p = 0.03) as well as in total wake time (48.3 and 42.2 min, p = 0.03) during CGMS use as compared with the period prior to CGMS use. Although self-perception of sleep quality remained unchanged, CGMS use appeared to affect actual parental sleep continuity somewhat negatively. This should be made clear to parents who may hold expectations of improvement in sleep quality following initiation of CGMS use.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type I Diabetes I: Introduction
Pulse rhythm
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
Glucose Homeostasis: Regulation of Blood Glucose
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...

